Eisai CEO retires

Share this article:

Eisai's president and CEO Lonnel Coats is retiring. The company announced Monday that Coats will leave the company in June, but will hand off his titles April 1, the first day of the company's new fiscal year.

Yuji Matsue will be the new chairman and CEO and will oversee “the strategic direction of the Americas Region.” Shaji Procida, the new president and COO as of April 1, will “have full operating responsibility for the US Business.”

The new executive lineup accompanies an organizational change that also goes into effect April 1. The company noted in its third-quarter earnings for FY 2014 that the pharmaceutical businesses will be designated as follows in FY2015: Japan (prescription drugs, generic drugs and diagnostics), Americas (North, Central and South), Asia (China, South Korea, Taiwan, India and ASEAN), EMEA (Europe, Middle East, Africa and Oceania) and Consumer Healthcare Businesses.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.